Yahoo Finance • 5 months ago
Key Insights Insiders appear to have a vested interest in ImmunityBio's growth, as seen by their sizeable ownership A total of 2 investors have a majority stake in the company with 62% ownership 10% of ImmunityBio is held by Institutions... Full story
Yahoo Finance • 7 months ago
CULVER CITY, Calif., June 07, 2024--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX) announced today that its 2024 Annual Meeting of Stockholders will be held on Tuesday, June 11, 2024 at 9:30 a.m. Pacific Time. The Annual Meeting will be... Full story
Yahoo Finance • 11 months ago
Patient Reported Outcomes (PROs) based on a May 16, 2022 data cutoff in the QUILT 3.032 trial indicate stability of physical function and global health in patients who completed PRO questionnaires and reached month 24 on-study Overall, par... Full story
Yahoo Finance • last year
Provides updated data on prolonged duration of complete response in BCG-Unresponsive and BCG-Naïve NMIBC patients Following the Type A Meeting with the FDA, ImmunityBio has completed the BLA resubmission addressing the issues in the Compl... Full story
Yahoo Finance • last year
SAN DIEGO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of ImmunityBio, Inc. (NASDAQ: IBRX). Investors, who purchased ImmunityBio, Inc. (NASDAQ:... Full story
Yahoo Finance • last year
NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) -- ImmunityBio, Inc. (NASDAQ: IBRX) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that th... Full story
Yahoo Finance • last year
SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Baxter International, Inc. (NYSE: BAX) Johnson Fistel, LLP is investigating potential claims on behalf of Baxter International, Inc. (NYSE: BAX). If you are a current, long-term shareholde... Full story
Yahoo Finance • last year
NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) -- Arrow Financial Corp. (NASDAQ: AROW) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations tha... Full story
Yahoo Finance • last year
SAN FRANCISCO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022 – May 10, 2023 Lead Plaintiff Deadlin... Full story
Yahoo Finance • last year
NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ImmunityBio, Inc. ("ImmunityBio" or the "Company") (NASDAQ: IBRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recov... Full story
Yahoo Finance • last year
LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story
Yahoo Finance • last year
NEW YORK, Aug. 26, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX), and certain officers. The class action, filed in... Full story
Yahoo Finance • last year
NEW YORK, Aug. 25, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between May 23, 2022 and May 10, 2023, both dates inclusive (the “Cl... Full story
Yahoo Finance • last year
BENSALEM Pa. , Aug. 24, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story
Yahoo Finance • last year
NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ImmunityBio, Inc. (NASDAQ: IBRX) alleging that the Company violated federal securities law... Full story
Yahoo Finance • last year
NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of ImmunityBio, Inc. (NASDAQ: IBRX)?Did you purchase your shares between May 23, 2022 and May 10, 2023, inclusive?Did you lose money in y... Full story
Yahoo Finance • last year
NEW YORK, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of ImmunityBio, Inc. (NASDAQ... Full story
Yahoo Finance • last year
NEW YORK, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ImmunityBio, Inc. (“ImmunityB... Full story
Yahoo Finance • last year
ATLANTA, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the filed class action lawsuit against ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) and the upcoming August 29, 2023 Lead Plaintiff... Full story
Yahoo Finance • last year
NEW YORK, Aug. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between May 23, 2022 and May 10, 2023, both dates inclusive (the “Cl... Full story